{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,7]],"date-time":"2025-06-07T11:04:19Z","timestamp":1749294259631},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T00:00:00Z","timestamp":1690761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-023-03015-y","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T04:01:35Z","timestamp":1690776095000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic impact of lung recurrence in patients with biliary tract cancer"],"prefix":"10.1007","volume":"408","author":[{"given":"Tatsuaki","family":"Sumiyoshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichiro","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuta","family":"Shintakuya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenjiro","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Serikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasutaka","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Arihiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyunji","family":"Murashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinya","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,31]]},"reference":[{"key":"3015_CR1","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1097\/00000658-200110000-00010","volume":"234","author":"WR Jarnagin","year":"2001","unstructured":"Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bodniewicz BSJ et al (2001) Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 234:507\u2013517","journal-title":"Ann Surg"},{"key":"3015_CR2","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","volume":"341","author":"PC de Groen","year":"1999","unstructured":"de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341:1368\u20131378","journal-title":"N Engl J Med"},{"key":"3015_CR3","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","volume":"15","author":"S Rizvi","year":"2018","unstructured":"Rizvi S, Khan SA, Hallemeier CL, Kelley RK, Gores GJ (2018) Cholangiocarcinoma \u2013 evolving concepts and therapeutic strategies. Nat Rev Clin Oncol 15:95\u2013111","journal-title":"Nat Rev Clin Oncol"},{"key":"3015_CR4","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/S0168-8278(02)00297-0","volume":"37","author":"SA Khan","year":"2002","unstructured":"Khan SA, Taylor-Robinson SD, Toledano MB, Beck A, Elliott P, Thomas HC (2002) Changing international trends in mortality rates for liver, biliary and pancreatic tumours. J Hepatol 37:806\u2013813","journal-title":"J Hepatol"},{"key":"3015_CR5","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1136\/gut.48.6.816","volume":"48","author":"SD Taylor-Robinson","year":"2001","unstructured":"Taylor-Robinson SD, Toledano MB, Arora S, Keegan TJ, Hargreaves S, Beck A et al (2001) Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968\u20131998. Gut 48:816\u2013820","journal-title":"Gut"},{"key":"3015_CR6","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1007\/s11605-013-2251-0","volume":"17","author":"Y Murakami","year":"2013","unstructured":"Murakami Y, Uemura K, Sudo T, Hashimoto Y, Kondo N, Nakagawa N et al (2013) Perineural invasion in extrahepatic cholangiocarcinoma: prognostic impact and treatment strategies. J Gastrointest Surg 17:1429\u20131439","journal-title":"J Gastrointest Surg"},{"key":"3015_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/cncr.24766","volume":"116","author":"M Nagahashi","year":"2010","unstructured":"Nagahashi M, Shirai Y, Wakai T, Sakata J, Ajioka Y, Nomura T et al (2010) Depth of invasion determines the postresectional prognosis for patients with T1 extrahepatic cholangiocarcinoma. Cancer 116:400\u2013405","journal-title":"Cancer"},{"key":"3015_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1001\/archsurg.136.2.209","volume":"136","author":"D Blom","year":"2001","unstructured":"Blom D, Schwartz SI (2001) Surgical treatment and outcomes in carcinoma of the extrahepatic bile ducts: the University of Rochester experience. Arch Surg 136:209\u2013215","journal-title":"Arch Surg"},{"key":"3015_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/bjs.9367","volume":"101","author":"K Kamposioras","year":"2014","unstructured":"Kamposioras K, Anthoney A, Fern\u00e1ndez Moro C, Cairns A, Smith AM, Liaskos C et al (2014) Impact of intrapancreatic or extrapancreatic bile duct involvement on survival following pancreatoduodenectomy for common bile duct cancer. Br J Surg 101:89\u201399","journal-title":"Br J Surg"},{"key":"3015_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/01.sla.0000150166.94732.88","volume":"241","author":"JY Jang","year":"2005","unstructured":"Jang JY, Kim SW, Park DJ, Ahn YJ, Yoon YS, Choi MG et al (2005) Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 241:77\u201384","journal-title":"Ann Surg"},{"key":"3015_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.surg.2004.10.008","volume":"137","author":"Y Sakamoto","year":"2005","unstructured":"Sakamoto Y, Kosuge T, Shimada K, Sano T, Ojima H, Yamamoto J et al (2005) Prognostic factors of surgical resection in middle and distal bile duct cancer: an analysis of 55 patients concerning the significance of ductal and radial margins. Surgery 137:396\u2013402","journal-title":"Surgery"},{"key":"3015_CR12","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1056\/NEJMoa0908721","volume":"362","author":"J Valle","year":"2010","unstructured":"Valle J, Wasan H, Palmer DH et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. ABC-02 Trial Investigators. N Engl J Med 362:1273\u20131281","journal-title":"N Engl J Med"},{"key":"3015_CR13","doi-asserted-by":"publisher","first-page":"1950","DOI":"10.1093\/annonc\/mdz402","volume":"30","author":"C Morizane","year":"2019","unstructured":"Morizane C, Okusaka T, Mizusawa J et al (2019) Combination gemcitabine plus S-1 versus gemcitabine plus cisplatin for advanced\/recurrent biliary tract cancer: the FUGA-BT (JCOG1113) randomized phase III clinical trial. Ann Oncol 30:1950\u20131958","journal-title":"Ann Oncol"},{"key":"3015_CR14","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.pan.2020.08.019","volume":"20","author":"H Otsuka","year":"2020","unstructured":"Otsuka H, Uemura K, Kondo N, Sumiyoshi T, Nakagawa N, Okada K et al (2020) Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma. Pancreatology 20:1472\u20131478","journal-title":"Pancreatology"},{"key":"3015_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pan.2019.11.015","volume":"20","author":"H Kurahara","year":"2020","unstructured":"Kurahara H, Maemura K, Mataki Y, Tanoue K, Iino S, Kawasaki Y et al (2020) Lung recurrence and its therapeutic strategy in patients with pancreatic cancer. Pancreatology 20:89\u201394","journal-title":"Pancreatology"},{"key":"3015_CR16","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1002\/jhbp.1127","volume":"29","author":"Y Homma","year":"2022","unstructured":"Homma Y, Endo I, Matsuyama R, Sho M, Mizuno S, Seyama Y et al (2022) Outcomes of lung metastasis from pancreatic cancer: a nationwide multicenter analysis. J Hepatobiliary Pancreat Sci 29:552\u2013561","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3015_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0140-6736(22)02038-4","volume":"401","author":"K Nakachi","year":"2023","unstructured":"Nakachi K, Ikeda M, Konishi M, Nomura S, Katayama H, Kataoka T et al (2023) Adjuvant S-1 compared with observation in resected biliary tract cancer (JCOG1202, ASCOT): a multicentre, open-label, randomised, controlled, phase 3 trial. Lancet 401:195\u2013203","journal-title":"Lancet"},{"key":"3015_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/SLA.0b013e3182708b57","volume":"258","author":"M Nagino","year":"2013","unstructured":"Nagino M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Takahashi Y et al (2013) Evolution of surgical treatment for perihilar cholangiocarcinoma: a single-center 34-year review of 574 consecutive resections. Ann Surg 258:129\u2013140","journal-title":"Ann Surg"},{"key":"3015_CR19","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1007\/s00535-018-1469-8","volume":"53","author":"T Orimo","year":"2018","unstructured":"Orimo T, Kamiyama T, Mitsuhashi T, Kamachi H, Yokoo H, Wakayama K et al (2018) Impact of tumor localization on the outcomes of surgery for an intrahepatic cholangiocarcinoma. J Gastroenterol 53:1206\u20131215","journal-title":"J Gastroenterol"},{"key":"3015_CR20","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/jso.20903","volume":"97","author":"Y Murakami","year":"2008","unstructured":"Murakami Y, Uemura K, Hayashidani Y, Sudo T, Hashimoto Y, Nakagawa N et al (2008) No mortality after 150 consecutive pancreatoduodenctomies with duct-to-mucosa pancreaticogastrostomy. J Surg Oncol 97:205\u2013209","journal-title":"J Surg Oncol"},{"key":"3015_CR21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1097\/SLA.0b013e3181b0fc8b","volume":"250","author":"Y Murakami","year":"2009","unstructured":"Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H et al (2009) Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 250:950\u2013956","journal-title":"Ann Surg"},{"key":"3015_CR22","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1097\/SLA.0000000000002734","volume":"269","author":"VP Groot","year":"2019","unstructured":"Groot VP, Gemenetzis G, Blair AB, Rivero-Soto RJ, Yu J, Javed AA et al (2019) Defining and predicting early recurrence in 957 patients with resected pancreatic ductal adenocarcinoma. Ann Surg 269:1154\u20131162","journal-title":"Ann Surg"},{"key":"3015_CR23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/SLA.0000000000000827","volume":"262","author":"Y Takahashi","year":"2015","unstructured":"Takahashi Y, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T et al (2015) Surgery for recurrent biliary tract cancer: a single-center experience with 74 consecutive resections. Ann Surg 262:121\u2013129","journal-title":"Ann Surg"},{"key":"3015_CR24","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1007\/s00268-017-3877-y","volume":"41","author":"M Yamada","year":"2017","unstructured":"Yamada M, Ebata T, Yokoyama Y, Igami T, Sugawara G, Mizuno T et al (2017) Pulmonary metastasis after resection of cholangiocarcinoma: incidence, resectability, and survival. World J Surg 41:1550\u20131557","journal-title":"World J Surg"},{"key":"3015_CR25","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2005.05.050","volume":"237","author":"T Oshikiri","year":"2006","unstructured":"Oshikiri T, Morita T, Fujita M, Miyasaka Y, Senmaru N, Yamada H, Kaji N, Kondo S (2006) Resection of lung metastasis from gallbladder carcinoma: immunohistochemistry of RCAS1 and CD8+T cells in primary and metastatic tumors. Cancer Lett 237:115\u2013122","journal-title":"Cancer Lett"},{"key":"3015_CR26","doi-asserted-by":"publisher","first-page":"404","DOI":"10.5761\/atcs.cr.10.01611","volume":"17","author":"T Goto","year":"2011","unstructured":"Goto T, Urakami H, Akanabe K, Maeshima A, Kato R (2011) Solitary pulmonary metastasis from carcinoma of the papilla of vater. Ann Thorac Cardiovasc Surg 17:404\u2013407","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"3015_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/1759-7714.12418","volume":"8","author":"GY Pih","year":"2017","unstructured":"Pih GY, Kim DK, Park KM, Chang HM (2017) Bilateral lung metastasectomy in carcinoma of the ampulla of Vater. Thorac Cancer 8:124\u2013127","journal-title":"Thorac Cancer"},{"key":"3015_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13256-018-1671-6","volume":"12","author":"T Sakamoto","year":"2018","unstructured":"Sakamoto T, Honjo S, Morimoto M, Amisaki M, Arai Y, Tokuyasu N et al (2018) Successful resection of a slow-growing synchronous pulmonary metastasis from distal cholangiocarcinoma resected 3.5 years after initial surgery: a case report. J Med Case Rep 12:136","journal-title":"J Med Case Rep"},{"key":"3015_CR29","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.hpb.2021.01.007","volume":"23","author":"J Sakata","year":"2021","unstructured":"Sakata J, Nomura T, Aono T, Kitami C, Yokoyama N, Minagawa M et al (2021) Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates? HPB 23:1371\u20131382","journal-title":"HPB"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-023-03015-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-023-03015-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:09:14Z","timestamp":1705622954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-023-03015-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,31]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3015"],"URL":"https:\/\/doi.org\/10.1007\/s00423-023-03015-y","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,31]]},"assertion":[{"value":"14 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"290"}}